Harriet Clarfelt

September 09, 2021
Emis ups dividend despite earnings dip
The healthcare software group’s cash flows were knocked by deferred VAT repayments
September 07, 2021
Gamma flags strong start to 2021
The communications services provider posted strong UK organic growth, supported by deal activity in Spain and Germany
August 26, 2021
AstraZeneca pay out looks well protected
The UK's largest listed company's yield is down from its peak. But on balance, that looks a positive sign for long-term investors.
August 06, 2021
Hikma lifts guidance on generics division revenue surge
The FTSE 100 company expects generics' revenues to reach a higher range than previously forecast
August 05, 2021
Medtronic en route to recovery
Medical devices constitute a large and competitive market, but the Dublin-headquartered group arguably has the scale and investment power to fight its corner
August 05, 2021
WPP upgrades guidance, citing recovery
The media group has made various new business wins and upped the dividend
August 03, 2021
Coats ups dividend, flagging ‘positive momentum’
The FTSE 250 company’s organic sales are up one per cent against 2019
July 30, 2021
IAG expects more flying in Q3 - but uncertainties abound
Airborne uncertainties still linger
July 29, 2021
Q2 sales soar at Smith & Nephew
The group’s revenues were badly hit by the postponement of elective procedures last year
July 29, 2021
Beyond vaccines
Harriet Clarfelt considers the outlook for pharmaceutical companies in light of pipeline, regulatory and political pressures

1
2
3
4
5
6
7
8
9
...

Load More Articles